Fay key facts
as of Oct 2026- Developer of a digital healthcare platform designed for medical nutrition therapy and insurance-integrated dietary counseling.
- Fay is valued at approximately $500.0M as of Oct 2026 (last reported valuation).
- It has raised $75.0M; the latest was Early Stage VC ($50.0M) in Feb 2025.
- Notable investors include General Catalyst, Forerunner Ventures, Goldman Sachs Growth Equity, 1984 Ventures, Jake Cooper — 6 tracked in total.
- Status: Privately Held (backing).
Fay's last reported valuation, Feb 2025. Nothing priced has surfaced since.
- ·Watch Fay: the Monday email on marks, rounds and moves
Fay funding rounds
No funding rounds for Fay are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Fay valuation
Fay's last reported valuation was $500 million in Feb 2025. No priced round, secondary trade or fund mark has surfaced since.
Fay investors
6 investors are on record for Fay, including General Catalyst, Forerunner Ventures, Goldman Sachs Growth Equity and 1984 Ventures.
About Fay
Developer of a digital healthcare platform designed for medical nutrition therapy and insurance-integrated dietary counseling. The company's platform connects patients with a nationwide network of board-certified registered dietitians and managing automated insurance credentialing, telehealth scheduling, and HIPAA-compliant communication, enabling healthcare providers to achieve better chronic disease management and proactive wellness outcomes.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2021
- Employees
- 33
- Website
- faynutrition.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.